NCT05545150View on ClinicalTrials.gov

Volumetric Specimen Imager Device for the Intraoperative Imaging of Patients With Breast Carcinoma and Breast Ductal Carcinoma In Situ, The VIVID Study

PHASE2Active, not recruitingINTERVENTIONAL

Enrollment

113

Participants

Timeline

Start Date

November 28, 2022

Primary Completion Date

July 26, 2024

Study Completion Date

July 1, 2026

Conditions

Anatomic Stage 0 Breast Cancer AJCC v8Bilateral Breast CarcinomaBreast Ductal Carcinoma In SituInvasive Breast CarcinomaMulticentric Breast CarcinomaPrognostic Stage 0 Breast Cancer AJCC v8

Interventions

PROCEDURE

Intraoperative Imaging

Clarix Imaging Volumetric Specimen Imager

DEVICE

Lumpectomy

Per standard of care (SOC)

Trial Locations (4)

40536

The University of Kentucky, Lexington

44195

Cleveland Clinic, Cleveland

60611

Northwestern University, Chicago

63110

Washington University in St. Louis, St Louis

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

lead

Northwestern University

OTHER